期刊文献+

中国脊髓性肌萎缩症患儿的SMN基因学研究 被引量:5

Study of SMN gene in Chinese children with spinal muscular atrophy
原文传递
导出
摘要 目的明确中国人各型脊髓性肌萎缩症(SMA)患儿SMN1基因外显子7和8缺失,SMN基因转变及微小突变情况。方法对106例患者,采用PCR-RFLP检测基因缺失,RFLP筛查基因转变,并对PCR产物进行测序分析。基因转变率比较采用Fisher精确检验法进行统计学分析。结果 SMA患儿纯合SMN1外显子7和/或8缺失比率为91.5%,发现1例SMA中存在SMN1外显子7保留,而SMN1非编码外显子8缺失。在SMN1外显子7缺失而无外显子8缺失的患者中,各型间基因转变率差别无统计学意义,在SMN1外显子7缺失的SMA中,其基因转变率为8.3%。SMN第7外显子附近未发现基因微小突变。结论 SMN1基因外显子7和/或8缺失为中国SMA患儿的主要病因。SMA中存在SMN基因转变现象。SMN1基因外显子8的单独缺失可能致病。SMN1基因外显子7附近可能不是此病微小突变的热点区域。 Objective To study the incidence of homozygous absence of SMN1 exons 7 and 8,SMN gene conversion frequency and SMN subtle mutations in children with spinal muscular atrophy(SMA).Methods The homozygous deletion was detected by PCR-RFLP in 106 Chinese children with SMA,gene conversion by RFLP and subtle mutations by sequencing.Results The rate of deletion of SMN1 exons 7 and /or 8 was 91.5%.Deletion of SMN1 exon 8 but existence of exon 7 was noted in one child with SMA.There were no significant differences in the gene conversion frequency among children with different types of SMA and who had homozygous deletion of SMN1 exon 7 but existence of exon 8.The gene conversion frequency was 8.3% in children with homozygous deletion of SMN1 exon 7.No subtle mutations were found around SMN1 exon 7.Conclusions Deletion of SMN1 exons 7 and /or 8 is the main cause of SMA in Chinese children.There exists a SMN gene conversion phenomenon in SMA.Deletion of exon 8 might lead to SMA.The hot area of subtle mutations of this disease might not be around SMN1 exon 7.
出处 《中国当代儿科杂志》 CAS CSCD 北大核心 2010年第7期539-543,共5页 Chinese Journal of Contemporary Pediatrics
关键词 脊髓性肌萎缩 SMN基因缺失 基因转变 微小突变 儿童 Spinal muscular atrophy Deletion of SMN gene Gene conversion Subtle mutation Child
  • 相关文献

参考文献14

  • 1Prior TW. Spinal muscular atrophy diagnostics[ J]. J Child Neurol, 2007, 22(8):952-956.
  • 2Munsat TL, Davies KE. International SMA consortium meeting[J] Neuromuscul Disord, 1992, 2(5-6) :423-428.
  • 3Lefebvre S, Burglen L, Reboullet S, Clermont O, Burlet P, Viollet L, et al. Identification and characterization of a spinal muscular atrophy-determining gene[ J]. Cell, 1995, 80( 1 ) : 155-165.
  • 4卢丽萍,麻宏伟,姜俊,王涛,胡斌.脊髓性肌萎缩临床表型与SMN2基因拷贝数变化的相关性研究[J].中华医学遗传学杂志,2007,24(2):144-147. 被引量:11
  • 5Mazzei R, Gambardella A, Conforti FL, Magariello A, Patitueei A, Gabriele AL, et al. Gene conversion events in adult-onset spinal muscular atrophy [ J]. Acta Neurol Scand, 2004, 109 (2) : 151-154.
  • 6Wirth B. An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA) [J]. Hum Mutat, 2000, 15(3) :228-237.
  • 7Derakhshandeh-Peykar P, Esmaili M, Ousati-Ashtiani Z, Rahmani M, Babrzadeh F, Farshidi S, et al. Molecular analysis of the SMN1 and NAIP genes in iranian patients with spinal muscular atrophy [ J ]. Ann Acad Med Singapore, 2007, 36 ( 11 ) :937-941.
  • 8Zapletalova E, Hedvicakova P, Kozak L, Vondacek P, Gaillyova R, Marikova T, et al. Analysis of point mutations in the SMN1 gene in SMA patients bearing a single SMN1 copy[ J]. Neuromuscul Disord, 2007, 7(6) :476-481.
  • 9Banyer JL, Goldwurm S, Cullen L, van der Griend B, Zournazi A, Smit DJ, et al. The spinal muscular atrophy gene region at 5q 13.1 has a paralogous chromosomal region at 6p21.3 [ J] . Mamm Gehome, 1998, 9 (3) :235-239.
  • 10Kaindl AM, Guenther UP, Rudnik-Schoneborn S, Varon R, Zerres K, Schuelke M, et al. Spinal muscular atrophy with respiratory distress type 1 (SMARD1) [J]. J Child Neurol, 2008, 23(2) : 199 -204.

二级参考文献17

  • 1陈万金,吴志英,王柠,林珉婷,慕容慎行.脊髓性肌萎缩症运动神经元生存基因2拷贝数与临床表型的关系[J].中华神经科杂志,2005,38(11):673-676. 被引量:11
  • 2Munsat TL, Davies KE. International SMA consortium meeting. Neuro Dis, 1992,2:423-428.
  • 3Chang JG, Hsieh-Li HM, Jong YJ, et al. Treatment of spinal muscular atrophy by sodium butyrate. PNAS,2001,98:9808-9813.
  • 4Andreassi C, Angelozzi C, Tiziano FD, et al. Phenylbutyrate increases SMN expression in vitro: relevance for treatment of spinal muscular atrophy. Eur J Hum Genet ,2004,12:59-65.
  • 5Brichta L, Hofmann Y, Hahnen E, et al. Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy. Hum Mol Genet,2003,12:2481-2489.
  • 6Anhuf D, Eggermann T, Rudnik-Schoneborn S, et al. Determination of SMN1 and SMN2 copy number using TaqMan technology. Hum Mutat, 2003,22: 74-78.
  • 7Feldkotter M, Schwarzer V, Wirth R, et al. Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy.Am J Hum Genet ,2002,70:358-368.
  • 8Harada Y, Sutomo R, Sadewa AH, et al. Correlation between SMN2 copy number and clinical phenotype of spinal musollar atrophy: three SMN2 copies fail to rescue some patients from the disease severity. J Neurol,2002,249:1211-1219.
  • 9Sendtner M. molecular mechanism in spinal muscular atrophy: models and perspectives. Curr Opin Neurol,2001, 14:629-634.
  • 10DiDonato CJ,Parks RJ, Kothary R. Development of a gene therapy strategy for the restoration of survival motor neuron protein expression: implications for spinal muscular atrophy therapy. Hum Gene Ther,2003,20, 14: 179- 188.

共引文献10

同被引文献31

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部